melanotan-ii has been researched along with ng-nitroarginine methyl ester in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, H; Kurowski, S; Parker, E; Salisbury, B; Vemulapalli, R | 1 |
Bassi, M; da Silva, AA; do Carmo, JM; Hall, JE | 1 |
2 other study(ies) available for melanotan-ii and ng-nitroarginine methyl ester
Article | Year |
---|---|
Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NO.
Topics: alpha-MSH; Alprostadil; Anesthesia; Animals; Blood Pressure; Culture Techniques; Cyclic GMP; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Injections, Intravenous; Isometric Contraction; Male; Melanocyte-Stimulating Hormones; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Papaverine; Penis; Peptides, Cyclic; Phentolamine; Rabbits; Receptors, Corticotropin; Receptors, Melanocortin | 2001 |
Systemic but not central nervous system nitric oxide synthase inhibition exacerbates the hypertensive effects of chronic melanocortin-3/4 receptor activation.
Topics: alpha-MSH; Analysis of Variance; Animals; Blood Glucose; Body Weight; Catheters, Indwelling; Eating; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Hypertension; Insulin; Leptin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptor, Melanocortin, Type 3; Receptor, Melanocortin, Type 4; Telemetry | 2011 |